Australia markets closed

Unity Biotechnology, Inc. (UBX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5050-0.0150 (-0.99%)
At close: 04:00PM EDT
1.4900 -0.01 (-1.00%)
After hours: 06:53PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
5,020
0
236
4,784
0
Operating expenses
Research development
37,800
20,099
36,859
38,393
67,309
Selling general and administrative
20,773
18,966
20,949
23,056
24,025
Total operating expenses
58,573
39,065
57,808
61,449
91,334
Operating income or loss
-53,553
-39,065
-57,572
-56,665
-91,334
Interest expense
3,394
2,452
3,558
3,177
1,292
Total other income/expenses net
62
-1,217
15,441
-983
-2,414
Income before tax
-56,451
-39,860
-44,469
-60,725
-93,844
Income from continuing operations
-56,451
-39,860
-44,469
-60,725
-93,844
Net income
-56,451
-39,860
-44,469
-60,725
-93,844
Net income available to common shareholders
-56,451
-39,860
-44,469
-60,725
-93,844
Basic EPS
-3.20
-2.70
-4.68
-10.88
-18.45
Diluted EPS
-3.20
-2.70
-4.68
-10.88
-18.45
Basic average shares
14,383
14,774
9,494
5,582
5,086
Diluted average shares
14,383
14,774
9,494
5,582
5,086